» Articles » PMID: 34335899

Monaldi Cavernostomy for Lung Aspergillosis: A Case Report

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2021 Aug 2
PMID 34335899
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary aspergillosis in patients with respiratory failure can severely affect the pulmonary functional status and may aggravate it through pulmonary suppuration, by recruitment of new parenchyma and hemoptysis, which can sometimes be massive, with lethal risk by flooding the bronchus. The treatment consists of a combination of medical therapy, surgery and interventional radiology. In small lesions, less than 2-3 cm, medical therapy methods may be sufficient; however, in invasive forms (larger than 3 cm) surgical resection is necessary. Surgical resection is the ideal treatment; nevertheless, when lung function does not allow it, action must be taken to eliminate the favorable conditions of the infection. In such cases, whenever the lung cavity is peripheral, a cavernostomy may be performed. Four cases of lung cavernous lesions colonized with aspergillus, in which the need for a therapeutic gesture was imposed by repeated small to medium hemoptysis and by the progression of respiratory failure, were evaluated, one of which is presented in the current study. Cavernostomy closure can be realized either surgically with muscle flap or spontaneously by scarring, after closure of the bronchial fistulas by epithelization and granulation. There were no recurrences of hemoptysis or suppurative phenomena. There was one death, a patient with severe respiratory failure caused by superinfection with nonspecific germs. However, in the case presented in this study, the patient recovered following cavernostomy, which seems to be an effective and safe method for cases in which lung resection is not feasible.

Citing Articles

Pulmonary Crohn's Disease or Crohn's Disease with Lung Sarcoidosis? A Case Report and Literature Review.

Vlasceanu S, Bobocea A, Petreanu C, Badarau I, Moldovan H, Gheorghita D Healthcare (Basel). 2022; 10(11).

PMID: 36421591 PMC: 9690086. DOI: 10.3390/healthcare10112267.

References
1.
Binder R, Faling L, Pugatch R, Mahasaen C, Snider G . Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore). 1982; 61(2):109-24. DOI: 10.1097/00005792-198203000-00005. View

2.
Walsh T, Anaissie E, Denning D, Herbrecht R, Kontoyiannis D, Marr K . Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008; 46(3):327-60. DOI: 10.1086/525258. View

3.
Giron J, Poey C, Fajadet P, Sans N, Fourcade D, Senac J . CT-guided percutaneous treatment of inoperable pulmonary aspergillomas: a study of 40 cases. Eur J Radiol. 1999; 28(3):235-42. DOI: 10.1016/s0720-048x(97)00148-4. View

4.
Massard G, Roeslin N, Wihlm J, Dumont P, WITZ J, Morand G . Pleuropulmonary aspergilloma: clinical spectrum and results of surgical treatment. Ann Thorac Surg. 1992; 54(6):1159-64. DOI: 10.1016/0003-4975(92)90086-j. View

5.
Gefter W . The spectrum of pulmonary aspergillosis. J Thorac Imaging. 1992; 7(4):56-74. DOI: 10.1097/00005382-199209000-00009. View